CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

Basit Öğe Kaydı
dc.contributor.authorEsposito, F. M.
dc.contributor.authorLee, J.
dc.contributor.authorRha, S. Y.
dc.contributor.authorPenkov, K. D.
dc.contributor.authorMoisseev, A.
dc.contributor.authorVan den Eynde, M.
dc.contributor.authorPrenen, H.
dc.date.accessioned2025-05-10T19:27:51Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- SEP 09-13, 2022 -- ELECTR NETWORK
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Med Oncol
dc.description.sponsorshipSanofi
dc.description.sponsorshipSanofi.
dc.identifier.endpageS1124
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.issue7
dc.identifier.scopusqualityQ1
dc.identifier.startpageS1124
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7091
dc.identifier.volume33
dc.identifier.wosWOS:000866211601522
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleCARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu